Nuclear Medicine and Biology

Papers
(The H4-Index of Nuclear Medicine and Biology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes50
Editorial Board39
Radiolabeling yield dependency of post-dry distillation decay of astatine-21133
177Lu and 227Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry29
Retraction notice to “Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors”. [N29
Development of a novel Azabenzimidazoles-Based PET radioligands for γ-8 dependent transmembrane AMPA receptor regulatory protein imaging23
Longitudinal florzolotau (18F) PET study in a rat model of Alzheimer’s disease.22
Radiofluorination of Sterically Hindered Amides: Automation, Stability Studies, and Mechanism20
N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/19
Synthesis of [11C]Me-DPA and evaluation in transgenic mouse model of Alzheimer’s disease18
Synthesis of a porphyrin-PSMA conjugate and preliminary labelling with copper-6417
Indigenous preparation, quality control and evaluation of [90Y] Y-glass microspheres for treatment of liver cancer in India17
[11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics16
Versatile diphosphine platforms for molecular radio-pharmaceuticals based on technetium-99m and rhenium-18816
Simple method for the production of [11C]phosgene15
Chelator-based non-peptidic radiotracers for PET imaging of PD-L1 with copper-6415
Preclinical Evaluation of [18F]F-[natLu]Lu-DOTA-rhCCK-18, the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with high Target Affinity and Tumor Accumulation15
Preclinical evaluation of [155/161Tb]Tb-crown-TATE – a novel SPECT imaging agent targeting neuroendocrine tumors15
Automated One-pot and One-step Radiosynthesis of [18F]VAT for PET Imaging of Vesicular Acetylcholine Transporter15
Improving PET imaging of urothelial carcinoma using manual synthesis of [68Ga]Ga-FAPI-46 and automated synthesis of [18F]AlF-FAPI-7415
0.22334218025208